Perspectives by the Leerink Center for Pharmacoeconomics

Rejoignez le Dr Mel Whittington pour des discussions perspicaces avec des experts de l'industrie, explorant les effets sociétaux des innovations en santé et leur importance.

Épisodes récents

Voir plus

Aug 13, 2025

Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA

E6 •

May 21, 2025

Chief Science Officer, National Pharmaceutical Council, Jon Campbell, PhD

E5 • 33 mins

Apr 23, 2025

Head of U.S. Public Affairs and Patient Advocacy, Oncology with Sanofi, Elizabeth Franklin, PhD, MSW

E4 • 35 mins

Mar 26, 2025

Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute, Kirsten Axelsen

E3 • 25 mins

Feb 26, 2025

Managing Director of Pharmagellan and Professor of the Practice at Tufts University, Frank S. David, MD, PhD

E2 • 38 mins